Simulations Plus, Inc. is a provider in the biopharma sector, offering advanced software and consulting services that enhance drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. It operates through two segments: software and services. The Company’s business units include cheminformatics, physiologically based pharmacokinetics, clinical pharmacology and pharmacometrics, quantitative systems pharmacology, adaptive learning & insights and medical communications. The Company operates in biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry. It delivers simulation-enabled performance and intelligence solutions alongside medical communications support for clinical and commercial drug development. Its cutting-edge technology is licensed and utilized by pharmaceutical, biotechnology, and regulatory agencies worldwide.
企業コードSLP
会社名Simulations Plus Inc
上場日Jun 18, 1997
最高経営責任者「CEO」O'Connor (Shawn M)
従業員数212
証券種類Ordinary Share
決算期末Jun 18
本社所在地800 Park Offices Drive, Suite 401
都市RESEARCH TRIANGLE PARK
証券取引所NASDAQ OMX - NASDAQ BASIC
国United States of America
郵便番号27709
電話番号16617237723
ウェブサイトhttps://www.simulations-plus.com/
企業コードSLP
上場日Jun 18, 1997
最高経営責任者「CEO」O'Connor (Shawn M)